Enhabit, Inc. (NYSE:EHAB – Get Free Report) has earned an average rating of “Moderate Buy” from the six research firms that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $11.50.
Several research firms recently issued reports on EHAB. UBS Group upgraded shares of Enhabit from a “neutral” rating to a “buy” rating and increased their price target for the stock from $8.50 to $12.00 in a research report on Thursday. Truist Financial set a $10.50 target price on Enhabit and gave the company a “hold” rating in a report on Wednesday, January 7th. Weiss Ratings reissued a “sell (e+)” rating on shares of Enhabit in a report on Monday, December 29th. Wolfe Research set a $12.00 price objective on Enhabit in a research report on Thursday. Finally, Cowen upgraded shares of Enhabit to a “buy” rating in a research note on Tuesday.
Read Our Latest Stock Analysis on Enhabit
Institutional Investors Weigh In On Enhabit
Enhabit Stock Performance
NYSE EHAB opened at $10.18 on Tuesday. The firm has a 50-day moving average price of $9.05 and a two-hundred day moving average price of $8.21. Enhabit has a 12-month low of $6.47 and a 12-month high of $10.90. The company has a market capitalization of $515.03 million, a P/E ratio of -40.71 and a beta of 1.66. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 0.75.
Enhabit (NYSE:EHAB – Get Free Report) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.05. Enhabit had a positive return on equity of 3.91% and a negative net margin of 1.14%.The business had revenue of $263.60 million during the quarter, compared to analysts’ expectations of $267.08 million. Enhabit has set its FY 2025 guidance at 0.500-0.560 EPS. Analysts anticipate that Enhabit will post 0.22 earnings per share for the current year.
About Enhabit
Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.
The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.
Further Reading
- Five stocks we like better than Enhabit
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- This stock gets a 94 out of 100
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
